Your browser is no longer supported. Please, upgrade your browser.
ACT AdvisorShares Vice ETF daily Stock Chart
ACT [NASD]
AdvisorShares Vice ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week2.40%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.73%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter0.60%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-2.69%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-2.67%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range20.88 - 26.02 Perf YTD13.88%
Dividend0.37 P/FCF- EPS past 5Y- ROI- 52W High-6.34% Beta-
Dividend %1.52% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low16.71% ATR0.19
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)63.31 Volatility0.59% 0.48%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.82 Prev Close24.37
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.97K Price24.37
Recom- SMA201.89% SMA502.65% SMA200-0.89% Volume775 Change0.00%
Oct-23-19 12:32PM  More ETFs, please, survey says MarketWatch
Aug-19-19 01:41PM  Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs Zacks
Aug-12-19 12:00PM  ETFs in Focus as Consolidation Drives Marijuana Industry Zacks
Jul-11-19 10:41AM  YOLO Is the First NYSE-Listed Pot ETF to Bet on U.S. Marijuana Stocks Barrons.com
Jul-03-19 09:59AM  3 Charts Suggest Investors Will Be Buying Beer Stocks Investopedia
Jun-25-19 11:00PM  AbbVie hopes Botox-maker Allergan can iron out its wrinkles Financial Times
01:42AM  AbbVie/Allergan: not looking good Financial Times
May-20-19 05:26PM  Marijuana Stocks & ETFs: What Investors Need to Know Zacks
May-01-19 07:18AM  Allergan investors reject proposal to split chair, chief executive roles Financial Times
Apr-30-19 09:19PM  Allergan to prevail in vote over CEO Saunders' chairman role-sources Reuters
Apr-21-19 02:41PM  A Second Marijuana ETF Ignites Benzinga
Apr-18-19 11:15AM  New Marijuana ETF Goes Live ETF.com
Apr-17-19 12:02PM  YOLO? US Investors Are Getting Another Cannabis ETF Benzinga
Apr-16-19 01:30PM  AdvisorShares Launches Pure Cannabis ETF (Ticker: YOLO) PR Newswire
Apr-09-19 09:55PM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
Mar-27-19 08:11AM  Vice And Cannabis Are In With This ETF Benzinga
Mar-19-19 01:00PM  Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs Zacks
Mar-14-19 08:00AM  Marijuana Fund Smokes Competition Amid Flurry Of Positive News Investor's Business Daily
Mar-12-19 02:30PM  US Marijuana Market Warms Up to Merger Deals: ETFs in Focus Zacks
Mar-04-19 12:51PM  7 Consumer Staples ETFs to Buy Now InvestorPlace
Mar-01-19 01:00PM  Why Marijuana ETFs & Stocks Have More Room to Run Zacks
Feb-25-19 08:00AM  New ETFs To Consider, Plus Second Marijuana Play On The Way? Investor's Business Daily
Feb-21-19 02:31PM  ETFs and Stocks to Tap the Marijuana Boom Zacks
Feb-06-19 11:10AM  AdvisorShares Files for Marijuana ETF Zacks
11:07AM  Marijuana ETF Tops $1 Billion in AUM ETF Trends
Jan-30-19 05:32PM  AdvisorShares Eyes Marijuana ETF Listing Benzinga
Jan-29-19 04:40PM  Marijuana ETFs to Access Growing Cannabis Outlook ETF Trends
03:40PM  Marijuana ETF YOLO is in the Works ETF Trends
Dec-27-18 01:00PM  AdvisorShares Announces December 2018 Distributions PR Newswire
Nov-28-18 10:50AM  Another Cannabis ETF on the Way Zacks
Nov-26-18 12:16PM  3 Stocks That Are Absurdly Cheap Right Now Motley Fool
Nov-06-18 08:00AM  Will Cannabis ETFs be on a High Again? Zacks
Oct-15-18 08:02AM  This Sin-Stock ETF's Marijuana Moves Have Missed the Mark Motley Fool
Oct-11-18 01:45PM  Fans of Tilray Stock Ought to Ride MJ to Success InvestorPlace
Sep-17-18 08:52AM  The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE Zacks
Sep-14-18 01:25PM  4 ETFs Set to Soar in the Aftermath of Hurricane Florence Zacks
Sep-12-18 12:00PM  Why Bausch Health Companies Inc. Stock Is Booming Today Motley Fool
Aug-21-18 10:18AM  5 Vice ETFs That Are Worth Sinning For InvestorPlace
Aug-17-18 07:31AM  If I Had to Buy 1 Stock in August, It Would Be This One Motley Fool
Aug-02-18 07:42PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:48PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:16PM  Allergan sues Pfizer over costs of opioid litigation Reuters
02:31PM  Allergan Sues Pfizer Over Damages in Opioid Litigation Bloomberg
11:55AM  Marijuana ETFs: The Pros and Cons Investopedia
Jul-26-18 10:02AM  3 Charts Suggest It's Time to Invest in Sin Stocks Investopedia
Jul-02-18 11:26PM  Here Are the Only Two Marijuana ETFs U.S. Investors Need Consider InvestorPlace
Jun-21-18 10:55AM  Canada Legalizes Marijuana: Two ETFs to Tap the Boom Zacks
Jun-20-18 02:12PM  Marijuana ETFs Grow on Canadian Parliaments Ruling ETF Trends
May-21-18 03:44PM  Marijuana Stocks: This Unique Weed Merger Offers Tech, Eyes U.S. Listing Investor's Business Daily
May-17-18 12:40PM  Marijuana ETFs Experience Setbacks Investopedia
May-07-18 03:26PM  3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement InvestorPlace
Apr-20-18 10:54AM  4/20: Marijuana, hemp legalization moves ahead in many states Yahoo Finance Video
09:07AM  Futures point slightly lower, Trump bashes OPEC over oil prices Yahoo Finance
Feb-16-18 03:31PM  United Therapeutics reaches patent settlement with Actavis American City Business Journals
03:16PM  United Therapeutics settles patent litigation over $157M drug American City Business Journals
Feb-14-18 09:58AM  Marijuana and Blockchain: 2018's Hottest New ETFs Zacks
Feb-06-18 12:20PM  Allergan CEO: We Are Staying in Ireland TheStreet.com
Feb-01-18 08:49AM  Allergan to pay Israel's Teva Pharm $700 million to settle dispute Reuters
Jan-17-18 12:14AM  [$$] Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant The Wall Street Journal
Jan-16-18 06:02PM  [$$] Judge Signals He Will Approve Settlement Between Allergan Shareholders and Pershing, Valeant The Wall Street Journal
Jan-11-18 04:25PM  What Investors Need to Know About Marijuana ETFs Zacks
03:33PM  Ackmans Pershing Square cuts hedge-fund fees due to lawsuit settlement MarketWatch
Jan-10-18 09:52AM  'New' Fund Soars To Record High: Is Cannabis The New Bitcoin? Investor's Business Daily
Jan-04-18 04:12PM  Pot Stock Plays Fall, But Here's Why Jeff Sessions May Not Matter Much Investor's Business Daily
Dec-30-17 10:16AM  Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 Million Forbes
Dec-29-17 11:31PM  [$$] Pershing Square, Valeant to Pay $290 Million to Settle Allergan Suit The Wall Street Journal
02:16PM  Pershing Square, Valeant arrive at settlement split for Allergan lawsuit Reuters
01:28PM  Pershing Square, Valeant to Pay $290 Million to End Lawsuit Bloomberg
01:07PM  Valeant says parties in Allergan litigation have agreed to resolve claims of $290 million MarketWatch
Dec-28-17 02:27PM  Rush for Marijuana ETFs Getting Stronger Zacks
Dec-26-17 12:44AM  [$$] Judge Sides Against Ackman and Valeant in Preliminary Allergan Ruling The Wall Street Journal
Dec-20-17 08:00AM  This Week's ETF Launches: Introducing the First Quadruple-Leveraged Products ETF Database
Dec-13-17 02:58PM  Sin Is In With New Vice ETF ETF Trends
The investment seeks long-term capital appreciation. The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products. It will invest primarily in U.S. exchange listed equity securities, including common and preferred stock and ADRs.